Skip to main content

Table 3 Clinical Bentley analysis of circPTPN22

From: As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway

Parameter

No. of patients

circPTPN22(high)

circPTPN22(low)

P-value

Sex

 Male

72

34

38

0.456

 Female

48

26

22

Age (years)

 <60

43

18

25

0.183

 ≥60

77

42

35

Tumor size

 <5

72

27

45

0.001***

 ≥5

48

33

15

Differentiation grade

 Well-moderate

56

34

22

0.028*

 Poor-undifferentiation

64

26

38

T stage

 T1–T2

68

24

44

< 0.0001****

 T3–T4

52

36

16

Lymph node status

    

 Positive

75

24

51

< 0.0001****

 Negative

45

36

9

TNM stage

 I–II

52

15

37

< 0.0001****

 III–IV

68

45

23

Nerve/vascular invasion

 Positive

63

28

35

0.201

 Negative

57

32

25

  1. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001